Evidence map›Paper›PMID 35045679›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2021

[Alert in germline mutation predisposed to myeloid neoplasm: myelodysplastic syndromes accompanied with GATA2 deficeincy syndrome].

H Yao, X Yang, X Zhang, P Wang, X J Deng, M L Luo, T Chen, Y Q Liu, Y M Feng, L Gao and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

H YaoHematology Medical Center of Army Medical University Affiliated Second Hospital, Chongqing 400037, China.
X YangDepartment of Rheumatology and Immunology, Chongqing Medical University Affiliated Children's Hospital, Chongqing 400015, China.
X ZhangHematology Medical Center of Army Medical University Affiliated Second Hospital, Chongqing 400037, China.
P WangHematology Medical Center of Army Medical University Affiliated Second Hospital, Chongqing 400037, China.
X J DengHematology Medical Center of Army Medical University Affiliated Second Hospital, Chongqing 400037, China.
M L LuoDepartment of Pharmacy, Army Medical University Affiliated Second Hospital, Chongqing 400037, China.
T ChenHematology Medical Center of Army Medical University Affiliated Second Hospital, Chongqing 400037, China.
Y Q LiuHematology Medical Center of Army Medical University Affiliated Second Hospital, Chongqing 400037, China.
Y M FengHematology Medical Center of Army Medical University Affiliated Second Hospital, Chongqing 400037, China.
L GaoHematology Medical Center of Army Medical University Affiliated Second Hospital, Chongqing 400037, China.
P Y KongHematology Medical Center of Army Medical University Affiliated Second Hospital, Chongqing 400037, China.
Army Medical University · CNChildren's Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesMyeloproliferative DisordersNeoplasmsGATA2 Transcription FactorGerm-Line MutationHumansMutationGATA2 protein, humanGATA2 Transcription Factor

Identifiers

PMID35045679
PMCPMC8770874
OpenAlexW4206728508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.